Scolaris Content Display Scolaris Content Display

Cochrane Database of Systematic Reviews

Estrógenos para la esquizofrenia

Información

DOI:
https://doi.org/10.1002/14651858.CD004719.pub2Copiar DOI
Base de datos:
  1. Cochrane Database of Systematic Reviews
Versión publicada:
  1. 19 octubre 2005see what's new
Tipo:
  1. Intervention
Etapa:
  1. Review
Grupo Editorial Cochrane:

  1. Grupo Cochrane de Esquizofrenia

Copyright:
  1. Copyright © 2010 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

Cifras del artículo

Altmetric:

Citado por:

Citado 0 veces por enlace Crossref Cited-by

Contraer

Autores

  • Wan Lian LC Chua

    Correspondencia a: Craven and Airedale Drugs and Alcohol Team, Lynfield Hospital, Bradford, UK

    [email protected]

  • Angelica Izquierdo de Santiago

    The Mount, Leeds, UK

  • Jayashri Kulkarni

    Alfred Psychiatry Research Centre (APRC), Monash University, Melbourne, Australia

  • Ann Mortimer

    Department of Psychiatry, University of Hull, Hull, UK

Contributions of authors

Lian Chua ‐ thought of the review, instigated the work, wrote the protocol, analysed results and wrote review.

Angelica Izquierdo de Santiago ‐ helped write the protocol, analysed results and wrote review.

Jayashri Kulkarni ‐ helped write the protocol and commented on results and discussion.

Ann Mortimer ‐ helped write the protocol and commented on results and discussion.

Sources of support

Internal sources

  • University of Leeds, UK.

  • Monash University, Australia.

External sources

  • No sources of support supplied

Declarations of interest

Lian Chua ‐ None known.

Angelica Izquierdo de Santiago ‐ None known.

Jayashri Kulkarni ‐ has an active interest in this work and has undertaken potentially relevant studies. She has received multiple grants during her research career. These have included National Health & Medical Research Council (NH&MRC) project grants, Eli Lilly, Janssen Cilag, and Bristol Myer Squibb investigator initiated research grants, funding from the Stanley Foundation (Washington), NARSAD (New York) and several Victorian Government Health & Human Services innovative practice grants.

Anne Mortimer ‐ has no conflicts of interests regarding this review. She has received research and educational grants from Novartis, Eli Lilly, Janssen, AstraZeneca and Sanofi but these have been in connection with atypical antipsychotics.

Acknowledgements

We would like to thank the staff at the Cochrane Schizophrenia Review Group in Leeds, especially Professor Clive Adams and John Rathbone, for all their help and support. Thanks also to Professor Kim Good who provided us with unpublished data and supporting references.

Version history

Published

Title

Stage

Authors

Version

2005 Oct 19

Estrogen for schizophrenia

Review

Wan Lian LC Chua, Angelica Izquierdo de Santiago, Jayashri Kulkarni, Ann Mortimer

https://doi.org/10.1002/14651858.CD004719.pub2

2004 Jan 26

Oestrogen for schizophrenia

Protocol

Wan Lian Chua, Angelica Izquierdo de Santiago, Jayashri Kulkarni, Ann Mortimer

https://doi.org/10.1002/14651858.CD004719